Abstract
598TiP - APOLLON study: a phase I/II study for the safety and efficacy of panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have